Survivors of Hodgkin's disease: prevention of sequelae.
Increasing numbers of patients are surviving Hodgkin's disease in their youth, creating an ever larger cohort who need careful attention to long-term preventive medicine in their older years. Vigilance is especially needed for those who received laparotomy, splenectomy, and irradiation for early stage I through stage III disease, the majority of whom are destined to be long-term survivors. With the frequent migration of the young, these patients often fall under the care of a physician other than their original oncologist. The diligent internist, oncologist, emergency room physician, and general practitioner can avoid several simple pitfalls in the long-term care of these young patients now entering middle age.
Goffman
T E
TE
Radiation Oncology Branch, National Institutes of Health, National Cancer Institute, Bethesda, Md 20892.
Raubitschek
A
A
Glatstein
E
E
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011878:Radiotherapy / Q000009:adverse effects
D000970:Antineoplastic Agents